Co-existence of Hashimoto's thyroiditis with familial Mediterranean fever: Is there a pathophysiological association between the two diseases?

Clinical and Experimental Immunology

Volumn 156, Issue 2, 2009, Pages 373-376

  Gulcan, E ^a,b   Gulcan, A ^b   Koplay, M ^a   Alcelik, A ^c   Korkmaz, U ^d  

^a DUMLUPINAR UNIVERSITY   (Turkey)

^b Kutahya Evliya Celebi State Hospital   (Turkey)

^c Specialist MD Duzce State Hospital   (Turkey)

^d GAZI UNIVERSITY   (Turkey)

Author keywords

Associated diseases; Autoimmunity; Cytokines; Familial Mediterranean fever; Hashimoto's thyroiditis

Indexed keywords

COLCHICINE; LEVOTHYROXINE; LIOTHYRONINE; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNITY; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; ECHOGRAPHY; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENE AMPLIFICATION; GENE MUTATION; HASHIMOTO DISEASE; HUMAN; LIOTHYRONINE BLOOD LEVEL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TREATMENT RESPONSE;

ADULT; AUTOANTIBODIES; COLCHICINE; CYTOKINES; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HASHIMOTO DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IODIDE PEROXIDASE; THYROGLOBULIN; THYROID GLAND; YOUNG ADULT;

EID: 64649100020     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2009.03891.x     Document Type: Article

References (39)

1. Onen F. Familial Mediterranean fever. Rheumatol Int 2006 26 : 489 96.
2. Kiss MH, Magalhães CS. Autoinflammatory diseases: mimics of autoimmunity or part of its spectrum? Case presentation. J Clin Immunol 2008 28 (Suppl. 1 S84 9.
3. Papin S, Cuenin S, Agostini L et al. The SPRY domain of pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing. Cell Death Differ 2007 14 : 1457 66.
4. Caturegli P, Kimura H, Rocchi R, Rose NR. Autoimmune thyroid diseases. Curr Opin Rheumatol 2007 19 : 44 8.
5. Stassi G, DeMaria R. Autoimmune thyroid disease: new models of cell death in autoimmunity. Nat Rev Immunol 2002 2 : 195 204.
6. Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet 1998 351 : 659 64.
7. Livneh A, Langevitz P. Diagnostic and treatment concerns in familial Mediterranean fever. Bailliéres Best Pract Res Clin Rheumatol 2000 14 : 477 98.
8. El-Shanti HE. Familial Mediterranean fever. Saudi Med J 2001 22 : 104 9.
9. Bakkaloglu A. Familial Mediterranean fever. Pediatr Nephrol 2003 18 : 583 9.
10. Mijatovic V, Hompes PG, Wouters MG. Familial Mediterranean fever and its implications for fertility and pregnancy. Eur J Obstet Gynecol Reprod Biol 2003 108 : 171 6.
11. Ozen S. Familial Mediterranean fever: revisiting an ancient disease. Eur J Pediatr 2003 162 : 449 54.
12. Breuning MH, Bakker E. From gene to disease; marenostrine and familial Mediterranean fever. Ned Tijdschr Geneeskd 2000 144 : 1728 30.
13. Aypar E, Ozen S, Okur H et al. Th1 polarization in familial Mediterranean fever. J Rheumatol 2003 30 : 2011 3.
14. Ilfeld DN, Weil S, Kuperman O. Suppressor cell function in a family with familial Mediterranean fever. Clin Exp Immunol 1981 43 : 357 61.
15. Stojanov S, Kastner DL. Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol 2005 17 : 586 99.
16. Stjernberg-Salmela S, Ranki A, Karenko L, Pettersson T. The genetic background of tumour necrosis factor receptor-associated periodic syndrome and other systemic autoinflammatory disorders. Scand J Rheumatol 2004 33 : 133 9.
17. Horcada Rubio ML, Delgado Beltrán C, Armas Ramírez C. Autoinflammatory disorders: a new concept in hereditary periodic fever syndromes Ann Med Int 2004 21 : 143 7.
18. Granel B, Serratrice J, Dodé C, Grateau G, Disdier P, Weiller PJ. Overlap syndrome between FMF and TRAPS in a patient carrying MEFV and TNFRSF1A mutations. Clin Exp Rheumatol 2007 25 (4 Suppl. 45 S93 5.
19. Tunç R, Uluhan A, Melikoglu M, Ozyazgan Y, Ozdogan H, Yazici H. A reassessment of the International Study Group criteria for the diagnosis (classification) of Behçet's syndrome. Clin Exp Rheumatol 2001 5 Suppl. 24 S45 7.
20. Birlik M, Tunca M, Hizli N et al. Coexistence of familial Mediterranean fever with sacroiliitis and Behçet's disease: a rare occurrence. Clin Rheumatol 1998 17 : 397 9.
21. Koçak H, Cakar N, Hekimoglu B, Atakan C, Akkök N, Unal S. The coexistence of familial Mediterranean fever and polyarteritis nodosa; report of a case. Pediatr Nephrol 1996 10 : 631 3.
22. Duntas LH. Environmental factors and autoimmune thyroiditis. Nat Clin Pract Endocrinol Metab 2008 4 : 454 60.
23. Mori T, Kriss JP. Measurements by competitive binding radioassay of serum antimicrosomal and anti-thyroglobulin antibodies in Graves' disease and other thyroid disorders. J Clin Endocrinol Metab 1971 33 : 688.
24. Kiss MH, Magalhães CS. Autoinflammatory diseases: mimics of autoimmunity or part of its spectrum? Case presentation. J Clin Immunol 2008 28 (Suppl. 1 S84 9.
25. Shiohara M, Taniguchi S, Masumoto J et al. ASC, which is composed of a PYD and a CARD, is up-regulated by inflammation and apoptosis in human neutrophils. Biochem Biophys Res Commun 2002 293 : 1314 8.
26. Atkins MB, Mier JW, Parkinson DR, Gould JA, Berkman EM, Kaplan MM. Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells. N Engl J Med 1988 318 : 1557 63.
27. Nielsen CH, Hegedüs L, Rieneck K, Moeller AC, Leslie RG, Bendtzen K. Production of interleukin (IL)-5 and IL-10 accompanies T helper cell type 1 (Th1) cytokine responses to a major thyroid self-antigen, thyroglobulin, in health and autoimmune thyroid disease. Clin Exp Immunol 2007 147 : 287 95.
28. Drenth JP, van der Meer JW, Kushner I. Unstimulated peripheral blood mononuclear cells from patients with the hyper-IgD syndrome produce cytokines capable of potent induction of C-reactive protein and serum amyloid A in Hep3B cells. J Immunol 1996 157 : 400 4.
29. Papin S, Cazeneuve C, Duquesnoy P, Jeru I, Sahali D, Amselem S. The tumor necrosis factor alpha-dependent activation of the human Mediterranean fever (MEFV) promoter is mediated by a synergistic interaction between C/EBP beta and NF kappaB p65. J Biol Chem 2003 278 : 48839 47.
30. Köklü S, Oztürk MA, Balci M, Yüksel O, Ertenli I, Kiraz S. Interferon-gamma levels in familial Mediterranean fever. Joint Bone Spine 2005 72 : 38 40.
31. Centola M, Wood G, Frucht DM et al. The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood 2000 95 : 3223 31.
32. Karanikas G, Schuetz M, Wahl K et al. Relation of anti-TPO autoantibody titre and T-lymphocyte cytokine production patterns in Hashimoto's thyroiditis. Clin Endocrinol (Oxf) 2005 63 : 191 6.
33. Manukyan GP, Ghazaryan KA, ZhA K et al. Cytokine profile of Armenian patients with familial Mediterranean fever. Clin Biochem 2008 41 : 920 2.
34. Simsek I, Pay S, Pekel A et al. Serum proinflammatory cytokines directing T helper 1 polarization in patients with familial Mediterranean fever. Rheumatol Int 2007 27 : 807 11.
35. Haznedaroglu S, Oztürk MA, Sancak B et al. Serum interleukin 17 and interleukin 18 levels in familial Mediterranean fever. Clin Exp Rheumatol 2005 23 (4 Suppl 38 S77 80.
36. Choi EW, Shin IS, Bhang DH et al. Hormonal change and cytokine mRNA expression in peripheral blood mononuclear cells during the development of canine autoimmune thyroiditis. Clin Exp Immunol 2006 146 : 101 8.
37. Ajjan RA, Watson PF, Weetman AP. Detection of IL-12, IL-13, and IL-15 messenger ribonucleic acid in the thyroid of patients with autoimmune thyroid disease. J Clin Endocrinol Metab 1997 82 : 666 9.
38. Papanas N, Papazoglou D, Papatheodorou K, Antonoglou C, Kotsiou S, Maltezos E. Thyroxine replacement dose in patients with Hashimoto disease: a potential role for interleukin-6. Cytokine 2006 35 : 166 70.
39. de la Vega JR, Vilaplana JC, Biro A, Hammond L, Bottazzo GF, Mirakian R. IL-10 expression in thyroid glands: protective or harmful role against thyroid autoimmunity? Clin Exp Immunol 1998 113 : 126 35.